-
13
2023-12
Breakthrough｜Valgen Medtech's Transcatheter Hypertrophic Cardiomyopathy (HCM) Ablation Technique Successfully Used for Exploratory Clinical Application in 10 Patients2023-12-13
A team led by Profession Fang Zhenfei at the Second Xiangya Hospital of Central South University has once again applied the DragonFire myocardium RF ablation system and the transcatheter cardiomyopathy RF ablation needle and its guiding system……
-
11
2023-12
当西方遇见东方｜浙二王建安院士团队与全球结构性心脏病治疗专家就经导管瓣膜介入治疗展开深入技术交流2023-12-11
2023年12月10日，浙二王建安院士团队于浙大二院心脑血管病院区（博奥院区）应用DragonFly-T成功救治一例TpyeIIIB型三尖瓣反流患者。
-
30
2023-11
Big News｜Valgen DragonFly™ Transcatheter Mitral Valve Repair System Granted Marketing Approval in China by the NMPA2023-11-30
November 29, 2023 - Hangzhou Valgen Medtech Co., Ltd. (Valgen Medtech) announced that its in-house developed DragonFly™ Transcatheter Mitral Valve Repair System (DragonFly™) has been granted marketing approval by the National Medical Products Administrati
-
22
2023-11
Valgen Medtech and Venus Medtech reached a consensus on signing a letter of intent for exclusive cooperation on strategic marketing to speed up the promotion of techniques for diagnosis and treatment of valvular heart disease (VHD) in China2023-11-22
November 22, 2023 -- Venus MedTech (Hangzhou) Inc. (Venus Medtech) and Hangzhou Valgen Medtech Co., Ltd. (Valgen Medtech) reached a consensus on signing a letter of intent for exclusive cooperation on strategic marketing for the Valgen Medtech DragonFly™
-
25
2023-10
TCT 2023 | 德晋医疗DragonFly™，洞见二尖瓣修复治疗新趋势2023-10-25
第35届经导管心血管会议（TCT.2023）在美国旧金山拉开帷幕，会议主旨为介入心脏病专家和业内专业人士分享改善患者治疗质量的最新技术成果，浙江大学医学院附属第二医院王建安教授团队再次受邀以《DragonFly™ for Mitral Transcatheter Edge-to-Edge Repair in China》作专题演讲。
